Aggrecanase
Aggrecanases are proteolytic enzymes that are members of the ADAM protein (A Disintegrin And Metalloprotease) family. Aggrecanases act on large proteoglycans known as aggrecans, which are components of connective tissues such as cartilage. The inappropriate activity of aggrecanase is a mechanism by which cartilage degradation occurs in diseases such as arthritis. At least two forms of aggrecanase exist in humans: ADAMTS4 or aggrecanase-1[1] and ADAMTS11 or aggrecanase-2.[2] Both proteins contain thrombospondin (TS) motifs required for proper recognition of substrates.[3] Although both proteins can cleave the substrate aggrecan at the same position, they differ in kinetics and in secondary cleavage sites.[4]
References
- ↑ Tortorella MD et al. (1999). Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284(5420):1664-6. PMID 10356395
- ↑ Abbaszade I et al. (1999). Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274(33):23443-50. PMID 10438522
- ↑ Tortorella M, Pratta M, Liu RQ, Abbaszade I, Ross H, Burn T, Arner E. (2000). The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem 75(33):25791-7. PMID 10827174
- ↑ Tortorella MD, Liu RQ, Burn T, Newton RC, Arner E. (2002). Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21(6):499-511. PMID 12392761
 | This protein-related article is a stub. You can help WikiDoc by expanding it. |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
